机构地区:[1]中国人民解放军总医院老年心内科,北京100853 [2]中国人民解放军总医院老年超声科,北京100853 [3]中国人民解放军总医院心外科,北京100853
出 处:《中国病理生理杂志》2008年第6期1047-1050,共4页Chinese Journal of Pathophysiology
基 金:国家自然科学基金资助项目(No30470716);国家重点基础研究发展规划(973)资助项目(NoG2000056906)
摘 要:目的:探讨以重组腺相关病毒(rAAV)为载体的心肌肌浆网Ca2+-ATP酶(SERCA2a)基因转导对慢性心力衰竭犬心功能的影响。方法:选取成年比格犬17只,随机分为对照组4只和心力衰竭组11只。快速右心室起搏建立慢性心力衰竭犬模型并随机分为心力衰竭组4只、心力衰竭+绿色荧光蛋白(EGFP)组4只、心力衰竭+SERCA2a组5只(其中1只在开胸后死亡)。接受基因导入的心力衰竭犬行开胸术,分别向心肌内注射携带EGFP和SERCA2a基因的rAAV载体。于基因转导30d时停止起搏后进行超声心动图和血流动力学检查。结果:基因转导30d时,心力衰竭+SERCA2a组犬的症状及超声心动图指标与心力衰竭+EGFP组相比有显著好转(P<0.05);与对照组相比无显著差别。血流动力学监测发现,转导SERCA2a的犬LVSP、+dp/dtmax和-dp/dtmax明显升高,平均值较EGFP组分别增加54.12%[(214.72±31.74)mmHgvs(139.32±36.79)mmHg]、146.81%[(6779.43±217.58)mmHg/svs(2746.85±931.23)mmHg/s]和71.52%[(-4341.42±322.02)mmHg/svs(-2531.14±616.15mmHg/s)],LVEDP则降低了63.43%[(21.86±6.95)mmHgvs(59.78±6.92)mmHg],所有参数与对照组相比无显著差异。心力衰竭+EGFP组犬心肌冰冻切片在激光共聚焦显微镜下可见弥漫绿色荧光。结论:以rAAV为载体介导SERCA2a基因转导能够改善慢性心力衰竭犬心脏的收缩和舒张功能,是1种有前景的治疗慢性心力衰竭的方法。AIM: Abnormal Ca^2+ homeostasis is one basic cause of heart failure. Studies have recently shown that overexpression of sarcoplasmic reticulum (SR) Ca^2+ - ATPase (SERCA2a) by adenoviral/adeno - associated viral gene transfer restores contractile function ex vivo and in murine or rabbit models. We therefore hypothesized that an increase in SERC A2a protein will improve cardiac function in a pacing - induced big animal model of heart failure. METHODS : 17 beagles were randomized into control group (CG, n =4) and chronic heart failure group (n = 11 ). Four weeks after right ventricular rapid pacing (230 beats/min), 11 beagles all got heart failure (documented by 〉29. 3% decrease in ejection fraction). 4 of 11 were used as heart failure group (HF, n =4). 9 HF beagles were randomized to receive either a recombinant adeno - associated viral carrying the SERCA2a gene ( HF + SERC A2a, n = 5 ) or the reporter gene en- hanced green fluorescent protein (HF + EGFP, n =4) by thoracotomy. All HF beagles paced by 180 beats/min in order to maintain failing state. Thirty days after infection, parameters of systolic and diastolic function were measured by doppler echocardiography and hemodynamic monitor in all beagles. RESULTS: At 30 days after gene transfer, symptoms of HF + SERCA2a dogs improved. Echocardiogram parameters were superior to those in HF + EGFP group ( P 〈0. 05 ). Cardiac hemodynamic parameters of HF + SERCA2a dogs strikingly improved: LVSP, + dp/dtmax and -dp/dtmax increased, mean value increased respectively 54. 12% [ (214. 72±31.74) mmHg vs ( 139. 32±36. 79) mmHg], 146. 81% [ (6 779. 43±217.58) mmHg/s vs (2 746. 85±931.2) mmHg/s] and 71.52% [ ( -4 341.42±322.02) mmHg/s vs ( -2 531.14± 616. 15) mmHg/s] ; LVEDP lowered 63.43% [ (21.86±6. 95) mmHg vs (59. 78±6. 92) mmHg] compared with the dogs in HF + EGFP group. No significant difference in all parameters compared with those of control group was observed.
关 键 词:心力衰竭 充血性 肌浆网 CA^2+ 转运ATP酶 基因转移
分 类 号:R541.61[医药卫生—心血管疾病] R540.45[医药卫生—内科学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...